HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

eicosane

Networked: 13 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Acyclic Hydrocarbons
    - Alkanes: 241
      - eicosane: 13

Experts

1.	Bear, Joseph C: 2 articles (09/2016 - 02/2016)
2.	Mayes, Andrew G: 2 articles (09/2016 - 02/2016)
3.	Parkin, Ivan P: 2 articles (09/2016 - 02/2016)
4.	Southern, Paul: 2 articles (09/2016 - 02/2016)
5.	Dearling, Jason L J: 2 articles (01/2011 - 10/2007)
6.	Huston, James S: 2 articles (01/2011 - 10/2007)
7.	Packard, Alan B: 2 articles (01/2011 - 10/2007)
8.	Smith, Suzanne V: 2 articles (01/2011 - 10/2007)
9.	Treves, S Ted: 2 articles (01/2011 - 10/2007)
10.	Voss, Stephan D: 2 articles (01/2011 - 10/2007)

Related Diseases

1.	Neoplasms (Cancer) 02/01/1976 - "At a 20% alkane concentration level, the solutions containing octadecane and eicosane induced tumors most rapidly. " 10/30/2007 - "The objective of this work was to evaluate the novel chelating agent SarAr (1-N-(4-aminobenzyl)-3, 6,10,13,16,19-hexaazabicyclo[6.6.6] eicosane-1,8-diamine) for use in developing a new class of tumor-specific (64)Cu radiopharmaceuticals for imaging neuroblastoma and melanoma. " 01/01/2011 - "The chelators [S-2-(aminobenzyl)1,4,7-triazacyclononane-1,4,7-triacetic acid (p-NH(2)-Bn-NOTA): 6-[p-(bromoacetamido)benzyl]-1, 4, 8, 11-tetraazacyclotetradecane-N, N', N'', N'''-tetraacetic acid (BAT-6): S-2-(4-aminobenzyl)-1,4,7,10-tetraazacyclododocane tetraacetic acid (p-NH(2)-Bn-DOTA): 1,4,7,10-tetraazacyclododocane-N, N', N", N"'-tetraacetic acid (DOTA): and 1-N-(4-aminobenzyl)-3,6,10,13,16,19-hexaazabicyclo[6.6.6]eicosane-1,8-diamine (SarAr)] were conjugated to the anti-GD2 antibody ch14.18, and the modified antibody was labeled with (64)Cu and injected into mice bearing subcutaneous human melanoma tumors (M21) (n = 3-5 for each study). "
2.	Melanoma (Melanoma, Malignant) 10/30/2007 - "The objective of this work was to evaluate the novel chelating agent SarAr (1-N-(4-aminobenzyl)-3, 6,10,13,16,19-hexaazabicyclo[6.6.6] eicosane-1,8-diamine) for use in developing a new class of tumor-specific (64)Cu radiopharmaceuticals for imaging neuroblastoma and melanoma. " 01/01/2011 - "The chelators [S-2-(aminobenzyl)1,4,7-triazacyclononane-1,4,7-triacetic acid (p-NH(2)-Bn-NOTA): 6-[p-(bromoacetamido)benzyl]-1, 4, 8, 11-tetraazacyclotetradecane-N, N', N'', N'''-tetraacetic acid (BAT-6): S-2-(4-aminobenzyl)-1,4,7,10-tetraazacyclododocane tetraacetic acid (p-NH(2)-Bn-DOTA): 1,4,7,10-tetraazacyclododocane-N, N', N", N"'-tetraacetic acid (DOTA): and 1-N-(4-aminobenzyl)-3,6,10,13,16,19-hexaazabicyclo[6.6.6]eicosane-1,8-diamine (SarAr)] were conjugated to the anti-GD2 antibody ch14.18, and the modified antibody was labeled with (64)Cu and injected into mice bearing subcutaneous human melanoma tumors (M21) (n = 3-5 for each study). "
3.	Wounds and Injuries (Trauma) 04/01/2023 - "Wound dressing mats were fabricated by needleless electrospinning, and the resultant nanofiber mats were coated with a thermoresponsive eicosane/cellulose nanocrystals o/w system loaded with active α-aminophosphonate derivatives. " 01/20/2023 - "3. Naringin (NAR), eicosane (EIC), and octacosane (OCT) present in MP displayed antioxidant action and wound excision closure. "
4.	Hyperthermia 02/04/2016 - "A SPION-eicosane protective coating for water soluble capsules: Evidence for on-demand drug release triggered by magnetic hyperthermia." 09/27/2016 - "We present a drug delivery system for the GI tract based on coating standard gelatin drug capsules with a model eicosane- superparamagnetic iron oxide nanoparticle composite coating, which is activated using magnetic hyperthermia as an on-demand release mechanism to heat and melt the coating. "
5.	Weight Loss (Weight Reduction) 07/04/2016 - "Among the four kinds of materials, erythritol composite material has the highest melting point (118.5°C) and the highest enthalpy of fusion (266.3J/g), weight loss ratios of xylitol composite material after ten cycles is the lowest (2.1%), the compressive strength of xylitol composite material is the highest (9.08 MPa) and that of eicosane composite material is the lowest (3.32 MPa)."

Related Drugs and Biologics

1.	Diamines
2.	Chelating Agents
3.	Acids
4.	triazacyclononane
5.	dinutuximab
6.	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
7.	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)
8.	Polyamines
9.	nonadecane
10.	octadecane